ASH1L通过丝裂原活化蛋白激酶信号通路抑制牙髓炎中的基质金属蛋白酶
本研究探讨表观遗传调控因子ASH1L在牙髓炎中的作用。用TNF-α刺激人牙髓细胞并进行基因沉默实验,发现ASH1L经NF-κB和MAPK通路被诱导,ASH1L敲低上调MMP-1、MMP-2和MMP-13并激活MAPK通路,抑制MAPK可逆转MMP诱导,表明ASH1L通过MAPK通路抑制MMP。
要点
- TNF-α刺激人牙髓细胞后ASH1L是最强诱导的表观遗传介质之一。
- ASH1L敲低显著上调MMP-1、MMP-2和MMP-13的表达并影响MMP-2酶活性。
- 抑制MAPK信号通路可逆转ASH1L敲低对MMP的诱导作用。
核心结论
- ASH1L通过MAPK通路抑制牙髓炎过程中基质金属蛋白酶的发生和运作。
研究设计与样本
- 体外研究:用人牙髓细胞(HDPCs)以TNF-α刺激,并进行ASH1L小干扰RNA沉默。
- 动物实验:采用大鼠实验性牙髓炎组织进行免疫荧光检测。
主要发现
- TNF-α刺激HDPCs后,ASH1L成为最强诱导的表观遗传介质之一。
- TNF-α通过NF-κB和MAPK信号通路诱导ASH1L表达,ASH1L存在于细胞核和细胞质中,TNF-α尤其促进ASH1L在细胞质中积聚。
- 实验性牙髓炎组织中ASH1L含量增加,与体外结果一致。
- ASH1L敲低显著上调MMP-1、MMP-2和MMP-13的表达,并影响TNF-α刺激HDPCs中MMP-2的酶活性。
- ASH1L敲低激活TNF-α刺激HDPCs中的MAPK信号通路,抑制该通路可逆转MMP的诱导。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Pulpitis is an inflammation of dental pulp produced by a response to external stimuli. The response entails substantial cellular and molecular activities. Both genetic and epigenetic regulators contribute to the occurrence of pulpitis. However, the epigenetic mechanisms are still poorly understood. In this research, we studied the role of the absent, small, or homeotic-like (ASH1L) gene in the process of pulpitis. METHODS: Human dental pulp cells (HDPCs) were stimulated with proinflammatory cytokine tumor necrosis factor alpha (TNF-α). Gene expression profiling was performed to assess the occurrence of epigenetic regulators. Pulp tissue from rat experimental pulpitis was subjected to immunofluorescence to detect the occurrence of ASH1L and trimethylation of lysine 4 histone 3 (H3K4me3). The presence of ASH1L in HDPCs that had been generated by TNF-α stimulation was analyzed by Western blot procedures and cellular immunofluorescence. Once detected, ASH1L was silenced through the use of specific small interfering RNA. The effects of ASH1L on the occurrence and operation of matrix metalloproteinases (MMPs) were then tested by analysis of quantitative polymerase chain reactions, Western blotting, and zymography. Chromatin immunoprecipitation was performed to detect whether ASH1L and H3K4me3 were present in the promoter regions of MMPs. We then used Western blot procedures to examine the nuclear factor kappa B and the mitogen-activated protein kinase (MAPK) responses to the silencing of ASH1L. We also examined the specific pathway involved in ASH1L regulation of the MMPs. RESULTS: After stimulating HDPCs with TNF-α, ASH1L emerged as 1 of the most strongly induced epigenetic mediators. We found that TNF-α treatment induced the expression of ASH1L through the nuclear factor kappa B and MAPK signal pathways. ASH1L was found in both the nucleus and the cytoplasm. TNF-α treatment was particularly active in inducing the accumulation of ASH1L in cellular cytoplasm. As is also consistent with in vitro results, ASH1L was found in increased quantities in experimental dental pulpitis tissue. ASH1L knockdown markedly up-regulated the occurrence of MMP-1, MMP-2, and MMP-13. It also exercised an impact on the enzymatic activity of MMP-2 in HDPCs that had been stimulated with TNF-α. ASH1L knockdown activated the MAPK signal pathway in TNF-α-triggered HDPCs, the inhibition of which reversed the induction of MMPs. CONCLUSIONS: Our research identifies a mechanism by which ASH1L suppresses the occurrence and operation of MMPs during pulpitis. It does this through the MAPK pathway.
引用
- Bei Y, Tianqian H, Fanyuan Y, et al. ASH1L Suppresses Matrix Metalloproteinase through Mitogen-activated Protein Kinase Signaling Pathway in Pulpitis. J Endod. 2016. PMID: 28041684. doi:10.1016/j.joen.2016.10.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。